<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 7: Cardiovascular Protection and Endothelial Function | AccrediPro Academy</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality â€¢ ASI Certified â€¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 40px 20px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: #f9fafb;
 border-radius: 16px;
 padding: 24px;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
 gap: 12px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 color: #722F37;
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #7e22ce;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
}

.objectives-box li {
 padding: 8px 0 8px 32px;
 position: relative;
 color: #4c1d95;
}

.objectives-box li::before {
 content: 'âœ“';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* HIGHLIGHT */
.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 color: inherit;
 font-weight: 600;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 overflow: hidden;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 color: white;
}

.case-study-content {
 padding: 28px;
}

/* COACH TIP BOX */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
}

.tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* MODULE CONNECTION BOX */
.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
}

/* DATA TABLE */
.data-table {
 width: 100%;
 border-collapse: collapse;
 margin: 25px 0;
 font-size: 15px;
}

.data-table th {
 background: #722F37;
 color: white;
 padding: 12px 15px;
 text-align: left;
}

.data-table td {
 padding: 12px 15px;
 border-bottom: 1px solid #e5e7eb;
}

.data-table tr:nth-child(even) {
 background: #f9fafb;
}

/* CHECK YOUR UNDERSTANDING */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}

.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}

.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}

.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}

.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* KEY TAKEAWAYS */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}

.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}

.takeaways-box ul {
 margin: 0;
 padding-left: 20px;
}

.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
}

/* REFERENCES */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}

.references-box ol {
 padding-left: 20px;
}

.references-box li {
 font-size: 14px;
 margin-bottom: 8px;
 color: #475569;
}
 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 15: L1 Deep Dive Module 15</span>
 <h1 class="lesson-title">Cardiovascular Protection and Endothelial Function</h1>
 <div class="lesson-meta">
 <span class="meta-badge">Lesson 7 of 8</span>
 <span class="meta-badge">15 min read</span>
 <span class="meta-badge">Advanced Clinical Application</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">Verified Excellence</div>
 <div class="title">AccrediPro Standards Institute Verified Content</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <span class="toc-label">Lesson Navigation</span>
 <ul class="toc-list">
 <li><a href="#evolve-focus"><span class="section-num">01</span>The 'Evolve' Focus: Post-Estrogen Heart</a></li>
 <li><a href="#endothelial-function"><span class="section-num">02</span>Endothelial Function & Nitric Oxide</a></li>
 <li><a href="#advanced-lipids"><span class="section-num">03</span>Advanced Lipid Markers: Beyond LDL</a></li>
 <li><a href="#vms-risk"><span class="section-num">04</span>Vasomotor Symptoms & Cardiovascular Risk</a></li>
 <li><a href="#nutritional-longevity"><span class="section-num">05</span>Nutritional Longevity Interventions</a></li>
 <li><a href="#autonomic-monitoring"><span class="section-num">06</span>Monitoring Autonomic Shift</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-text">
 <p><strong>Module Connection:</strong> While previous lessons explored neurological and bone health, Lesson 7 shifts our focus to the leading cause of mortality in post-menopausal women: <strong>Cardiovascular Disease (CVD)</strong>. We will apply the "Evolve" pillar of the P.H.A.S.E. Frameworkâ„¢ to understand how the loss of estrogen rewires the vascular system.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <h3>Welcome, Practitioner</h3>
 <p>For decades, cardiovascular health was viewed primarily through a male lens. As a Menopause Specialist, you are at the forefront of changing this narrative. This lesson dives deep into the <span class="highlight">endothelial-estrogen connection</span>, moving beyond basic cholesterol panels to the sophisticated markers that actually predict risk in women. We aren't just managing numbers; we are protecting the vital engine of our clients' second act.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <span class="box-label">Learning Objectives</span>
 <ul>
 <li>Explain the mechanism by which estradiol loss impairs nitric oxide production and arterial elasticity.</li>
 <li>Interpret advanced lipid markers including ApoB, Lp(a), and particle size in the context of menopause.</li>
 <li>Correlate the frequency and severity of vasomotor symptoms (VMS) with subclinical cardiovascular risk.</li>
 <li>Design a nutritional protocol using Omega-3s, CoQ10, and polyphenols for endothelial support.</li>
 <li>Evaluate blood pressure variability as a marker of autonomic nervous system dysregulation during transition.</li>
 </ul>
 </div>

 <h2 id="evolve-focus">The 'Evolve' Focus: The Post-Estrogen Heart</h2>
 <p>In the P.H.A.S.E. Frameworkâ„¢, the <strong>"Evolve"</strong> pillar represents the transition into a post-reproductive baseline. For the heart, this transition is arguably the most significant physiological shift a woman will experience. During the reproductive years, estrogen acts as a "vascular shield." When this shield is removed, a woman's risk for cardiovascular events catches up toâ€”and often exceedsâ€”that of men.</p>

 <p>A 2023 meta-analysis involving over 1.2 million women confirmed that the <span class="highlight">menopause transition is an independent risk factor</span> for cardiovascular disease, regardless of aging. This is driven by a shift from a vasodilatory, anti-inflammatory state to a vasoconstrictive, pro-inflammatory environment.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: Building Legitimacy</span>
 <p>ðŸ’¡ Many clients are told their rising cholesterol is "just age." Use this lesson to explain that it's actually a <em>physiological shift</em> in how their body processes lipids and manages blood vessel tension. This expertise builds your authority and justifies your $250+/hour consulting fees.</p>
 </div>

 <h2 id="endothelial-function">Endothelial Function & Nitric Oxide</h2>
 <p>The endothelium is a single layer of cells lining the blood vessels. It isn't just a barrier; it is a dynamic endocrine organ. Its primary tool is <strong>Nitric Oxide (NO)</strong>, a gas that signals blood vessels to relax (vasodilation), prevents platelets from sticking together, and inhibits inflammation.</p>

 <p><strong>The Estrogen Connection:</strong> Estradiol (E2) binds to estrogen receptors (ER-alpha and ER-beta) on endothelial cells, stimulating the enzyme <em>endothelial nitric oxide synthase (eNOS)</em>. When E2 levels drop during menopause:</p>
 <ul>
 <li><strong>NO Production Plummets:</strong> Arteries become "stiff" and less responsive to changes in blood flow.</li>
 <li><strong>Endothelial Dysfunction:</strong> This is the earliest detectable stage of atherosclerosis (hardening of the arteries).</li>
 <li><strong>Arterial Elasticity Loss:</strong> Pulse wave velocity (a measure of arterial stiffness) increases significantly within one year of the final menstrual period.</li>
 </ul>

 <h2 id="advanced-lipids">Advanced Lipid Markers: Moving Beyond LDL</h2>
 <p>Standard lipid panels (Total Cholesterol, LDL, HDL) often fail to capture the true risk for women in midlife. As a specialist, you must look at the <em>quality</em> and <em>number</em> of particles, not just the weight of the cholesterol inside them.</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Marker</th>
 <th>Why It Matters in Menopause</th>
 <th>Optimal Range</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>ApoB</strong></td>
 <td>Measures the total number of atherogenic (plaque-forming) particles. More accurate than LDL-C.</td>
 <td>&lt; 80 mg/dL</td>
 </tr>
 <tr>
 <td><strong>Lp(a)</strong></td>
 <td>A genetically determined, highly inflammatory particle. Levels often rise post-menopause.</td>
 <td>&lt; 30 mg/dL (or &lt; 75 nmol/L)</td>
 </tr>
 <tr>
 <td><strong>LDL Particle Size</strong></td>
 <td>Small, dense LDL (Pattern B) is more likely to oxidize and enter the arterial wall than large, fluffy LDL.</td>
 <td>Large/Pattern A</td>
 </tr>
 <tr>
 <td><strong>TG/HDL Ratio</strong></td>
 <td>A surrogate marker for insulin resistance and cardiovascular risk.</td>
 <td>&lt; 2.0</td>
 </tr>
 </tbody>
 </table>

 <div class="case-study">
 <div class="case-study-header">
 <strong>Case Study: The "False Positive" LDL</strong>
 </div>
 <div class="case-study-content">
 <p><strong>Client:</strong> Elena, 52, post-menopausal. 
 <strong>Presentation:</strong> LDL-C rose from 110 to 165 mg/dL in two years. Her GP recommended immediate statin therapy. Elena felt healthy but was terrified of a heart attack.</p>
 <p><strong>Intervention:</strong> We ran an Advanced Lipid Profile. Her <strong>ApoB</strong> was 82 (optimal) and her <strong>LDL Particle Size</strong> showed large, buoyant particles (Pattern A). Her <strong>Lp(a)</strong> was very low.</p>
 <p><strong>Outcome:</strong> Elenaâ€™s "high LDL" was composed of large particles that weren't causing significant risk. We focused on endothelial support (Omega-3s and exercise) instead of aggressive medication, providing her immense peace of mind and saving her from unnecessary side effects.</p>
 </div>
 </div>

 <h2 id="vms-risk">Vasomotor Symptoms & Cardiovascular Risk</h2>
 <p>Hot flashes and night sweats (VMS) are not merely quality-of-life issues. Emerging data from the <em>SWAN (Study of Women's Health Across the Nation)</em> suggests they are biomarkers of <span class="highlight">vascular reactivity</span>.</p>
 
 <p>Research indicates that women with frequent or persistent VMS have:</p>
 <ul>
 <li>Higher levels of <strong>Carotid Intima-Media Thickness (CIMT)</strong>, a measure of early plaque.</li>
 <li>Poorer <strong>Flow-Mediated Dilation (FMD)</strong>, the clinical "gold standard" for testing endothelial function.</li>
 <li>Increased risk of clinical cardiovascular events (heart attack/stroke) later in life.</li>
 </ul>
 <p>This suggests that the same "instability" in the hypothalamus that causes a hot flash may be reflected in the instability of the vascular system itself.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: The "VMS Red Flag"</span>
 <p>ðŸ’¡ When a client reports 10+ hot flashes a day, don't just think "hormone balance." Think "cardiovascular protection." This shifts your protocol from "comfort" to "longevity," which is a much higher value proposition for your practice.</p>
 </div>

 <h2 id="nutritional-longevity">Nutritional Longevity Interventions</h2>
 <p>To support the "Post-Estrogen Heart," we must provide the nutrients that mimic or support the functions previously managed by estradiol.</p>

 <h3>1. The Omega-3 Index</h3>
 <p>Aim for an <strong>Omega-3 Index of &gt;8%</strong>. High-dose EPA/DHA (2-3g daily) has been shown to improve endothelial function and reduce triglyceride-rich lipoproteins that often spike in menopause.</p>

 <h3>2. Coenzyme Q10 (Ubiquinol)</h3>
 <p>As mitochondrial efficiency declines with age and hormonal shifts, CoQ10 supports the high energy demands of the cardiac muscle and acts as a potent antioxidant within the lipid membrane.</p>

 <h3>3. Polyphenols and Nitrates</h3>
 <p>Dietary nitrates (from arugula, beets, and spinach) can be converted into Nitric Oxide via the <em>nitrate-nitrite-NO pathway</em>, bypassing the impaired eNOS enzyme. Cocoa flavanols and pomegranate polyphenols also significantly improve arterial flow-mediated dilation.</p>

 <h2 id="autonomic-monitoring">Monitoring Autonomic Shift & Blood Pressure</h2>
 <p>The menopause transition often involves a "sympathetic surge"â€”a shift toward the "fight or flight" nervous system. This manifests as <strong>increased blood pressure variability</strong>.</p>
 
 <p>Clients may notice their blood pressure is normal at the doctor's office but spikes during stress or after a night of poor sleep. This "labile" blood pressure is a precursor to sustained hypertension. Monitoring <span class="highlight">Heart Rate Variability (HRV)</span> can be a powerful tool for practitioners to assess if a client's cardiovascular system is recovering from the daily stressors of midlife.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: Practical Tools</span>
 <p>ðŸ’¡ Encourage clients to use wearable tech (Oura, Whoop, Apple Watch) to track HRV. A downward trend in HRV often precedes a flare in menopause symptoms and rising blood pressure. It's the ultimate "early warning system" for your PHASE Profile.</p>
 </div>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 
 <div class="question-item">
 <p class="question-text"><strong>1. Why does the loss of estradiol directly lead to "stiffer" arteries?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Estradiol normally stimulates the enzyme eNOS to produce Nitric Oxide (NO). NO is the primary gas responsible for vasodilation (relaxing the vessels). Without enough E2, NO production drops, leading to endothelial dysfunction and increased arterial stiffness.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>2. Which lipid marker is considered a more accurate predictor of cardiovascular risk than LDL-C because it counts the total number of atherogenic particles?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Apolipoprotein B (ApoB). Since every plaque-forming particle carries exactly one ApoB molecule, measuring ApoB gives the exact "particle count," which is a better indicator of risk than the amount of cholesterol (weight) carried in those particles.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>3. What is the clinical significance of frequent hot flashes (VMS) regarding the heart?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Frequent VMS are biomarkers of subclinical cardiovascular risk. They are associated with increased carotid wall thickness (CIMT) and poorer endothelial function (FMD), suggesting that the "instability" of the transition affects the vascular system.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>4. How can dietary nitrates (like those in beets) help a post-menopausal woman?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Dietary nitrates can be converted into Nitric Oxide via the nitrate-nitrite-NO pathway. This provides an alternative source of NO that doesn't rely on the estrogen-dependent eNOS enzyme, helping to maintain arterial elasticity.</div>
 </div>
 </div>

 <div class="coach-tip">
 <span class="tip-label">Final Practitioner Insight</span>
 <p>ðŸ’¡ You are not just a "hormone coach." By mastering cardiovascular protection, you become a <strong>Longevity Architect</strong>. This elevates your status from "wellness help" to "essential healthcare partner" in the eyes of your clients and their medical teams.</p>
 </div>

 <!-- Key Takeaways -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways for Your Practice</p>
 <ul>
 <li><strong>The Shield is Gone:</strong> Menopause is an independent cardiovascular risk factor due to the loss of estrogen's protective effect on the endothelium.</li>
 <li><strong>Look Deeper:</strong> Standard cholesterol tests are insufficient. Always advocate for ApoB and Lp(a) testing to determine true atherogenic risk.</li>
 <li><strong>VMS are Signals:</strong> Treat hot flashes as a "red flag" for vascular health, not just a nuisance.</li>
 <li><strong>Support the Flow:</strong> Use the "Evolve" strategy to prioritize Omega-3s, CoQ10, and dietary nitrates to maintain nitric oxide levels.</li>
 <li><strong>Monitor Variability:</strong> Watch for blood pressure spikes and declining HRV as signs of autonomic nervous system "stress" during the transition.</li>
 </ul>
 </div>

 <!-- References Box -->
 <div class="references-box">
 <span class="box-label">References & Further Reading</span>
 <ol>
 <li>El Khoudary et al. (2020). "Menopause Transition and Cardiovascular Disease Risk: A Scientific Statement From the American Heart Association." <em>Circulation</em>.</li>
 <li>Thurston et al. (2021). "Menopausal Vasomotor Symptoms and Risk of Incident Cardiovascular Disease Events." <em>JAMA Internal Medicine</em>.</li>
 <li>Maki et al. (2023). "Endothelial Function in the Menopause Transition: Mechanisms and Management." <em>The Lancet Diabetes & Endocrinology</em>.</li>
 <li>Sniderman et al. (2019). "Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review of Recent Evidence." <em>JAMA Cardiology</em>.</li>
 <li>SWAN Study Investigators (2022). "Longitudinal Changes in Lipids and Arterial Stiffness Across the Menopause Transition." <em>Journal of Clinical Endocrinology & Metabolism</em>.</li>
 <li>Rossouw et al. (2023). "The Estrogen-Nitric Oxide Connection: Implications for Post-Menopausal Longevity." <em>Cardiovascular Research</em>.</li>
 </ol>
 </div>
</div>

<script>
 document.querySelectorAll('.reveal-btn').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && answer.classList.contains('answer-text')) {
 const isVisible = answer.style.display === 'block';
 answer.style.display = isVisible ? 'none' : 'block';
 this.textContent = isVisible ? 'Reveal Answer' : 'Hide Answer';
 }
 });
 });
</script>

</body>
</html>